ONOFRJ, Marco
 Distribuzione geografica
Continente #
NA - Nord America 14.111
EU - Europa 12.836
AS - Asia 7.380
SA - Sud America 568
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 33
Totale 35.023
Nazione #
US - Stati Uniti d'America 14.023
SG - Singapore 2.855
IT - Italia 2.800
CN - Cina 2.416
IE - Irlanda 2.212
UA - Ucraina 2.091
TR - Turchia 1.388
SE - Svezia 1.303
GB - Regno Unito 1.274
DE - Germania 967
FR - Francia 880
BR - Brasile 486
FI - Finlandia 481
IN - India 432
RU - Federazione Russa 382
AT - Austria 79
NL - Olanda 75
HK - Hong Kong 69
CA - Canada 65
BE - Belgio 61
VN - Vietnam 60
CZ - Repubblica Ceca 59
EU - Europa 31
IR - Iran 31
ZA - Sudafrica 28
JP - Giappone 27
LU - Lussemburgo 27
CH - Svizzera 25
AR - Argentina 22
AU - Australia 19
MX - Messico 19
CL - Cile 17
ES - Italia 16
PL - Polonia 15
NZ - Nuova Zelanda 14
RO - Romania 14
IQ - Iraq 13
PK - Pakistan 12
EC - Ecuador 10
IL - Israele 10
MA - Marocco 10
PT - Portogallo 9
UZ - Uzbekistan 9
VE - Venezuela 9
BD - Bangladesh 8
GR - Grecia 8
NO - Norvegia 8
PE - Perù 8
BG - Bulgaria 7
CO - Colombia 7
DK - Danimarca 7
LT - Lituania 7
AZ - Azerbaigian 6
HU - Ungheria 6
KR - Corea 6
TN - Tunisia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
PY - Paraguay 5
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
PH - Filippine 4
AL - Albania 3
DZ - Algeria 3
GH - Ghana 3
HR - Croazia 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BO - Bolivia 2
LK - Sri Lanka 2
MD - Moldavia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ID - Indonesia 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
Totale 35.023
Città #
Chandler 2.662
Jacksonville 2.442
Dublin 2.180
Singapore 1.908
Princeton 1.060
Southend 965
Izmir 751
Nanjing 682
Ashburn 537
Wilmington 515
Dearborn 412
The Dalles 409
Cambridge 376
Altamura 373
Beijing 372
Santa Clara 360
Chieti 317
Ann Arbor 312
Nanchang 241
Boardman 214
Woodbridge 193
Munich 191
New York 165
Rome 139
Los Angeles 136
Shenyang 128
Pescara 125
Hebei 123
Helsinki 118
Milan 113
Tianjin 111
Houston 106
Jiaxing 92
Washington 92
Kunming 91
Grevenbroich 86
Norwalk 77
Falls Church 74
Hangzhou 63
Changsha 62
Hong Kong 62
Jinan 55
Brussels 53
Dong Ket 52
Vienna 47
Brno 45
Nuremberg 45
Lanzhou 41
Seattle 39
São Paulo 39
London 34
Ningbo 32
Leawood 30
Taizhou 30
Toronto 30
Florence 29
Guangzhou 29
Castignano 28
Changchun 28
Orange 26
San Mateo 26
Ardabil 25
Hefei 25
Pune 25
Zhengzhou 25
Augusta 23
Shanghai 23
Capurso 22
Camerino 21
Frankfurt am Main 21
Bryanston 20
Cepagatti 20
Düsseldorf 19
Amsterdam 18
Naples 18
Belo Horizonte 17
Edinburgh 17
Montreal 17
Dudelange 16
Montesilvano 16
Catania 15
Chicago 15
Hanover 15
L'aquila 15
Moscow 15
Redwood City 15
Auburn Hills 14
Berkeley 14
Brasília 14
Paris 14
Rio de Janeiro 14
Teramo 14
Bologna 13
Romola 13
Turin 13
Berlin 12
Monmouth Junction 12
Ufa 12
Zurich 12
Campobasso 11
Totale 20.833
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 402
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 289
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 277
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 241
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 222
null 176
Pre-trattamento antiematico per Test/terapia all'apomorfina 164
Ambiguity resolution in relative clauses: An ERPs study. 147
REGIONE ABRUZZO. POTENZIAMENTO DELLA DIAGNOSI PRECOCE DEL DISTURBO NEUROCOGNITIVO MINORE TRAMITE IMPLEMENTAZIONE DI UN MINIMUM DATASET E DI TECNICHE DI INTELLIGENZA ARTIFICIALE 143
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 136
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 134
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 134
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 134
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 133
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 125
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 124
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 122
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 118
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 116
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 115
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 115
Ambiguity resolution and working memory span effects: An ERPs study 113
Noun animacy and ERP components modulation 112
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 112
"CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation 109
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 108
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 107
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 107
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 106
Progetto atrofia multisistemica: risultati preliminari. 106
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 104
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 103
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 103
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 102
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 101
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 100
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 100
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 100
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 99
BRAIN-STEM ACOUSTIC EVOKED-POTENTIALS (BAEPS) IN NEUROSURGICAL DISEASES 98
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 98
Akinetic crisis in Dementia with Lewy Bodies 98
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 95
Bipallidal lesions induce delayed and progressive parkinsonism 95
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 95
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 95
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 94
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 94
A combined EEG MEG fMRI study of the cortical activaties following pattern reversal visual stimuli 94
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 94
Attention network in AD and DLB patients: a resting fMRI study. 93
Holmes-Like Tremor in Ataxia With Oculomotor Apraxia Type 2 93
Stormy onset of benign childhood epilepsy with occipital paroxysmal discharges 92
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 92
Evoked Potentials (EPs) in Experimental Allergic Encephalomylitis: a study of EP modifications during the course of a controlled disease. 91
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 91
Neuromagnetic responses reveal the cortical timing of audiovisual synchrony 91
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 91
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 91
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 90
Instabilità posturale nel Parkinson non farmaco-responder 90
Improving diagnostic accuracy of DLB: An MRI study 90
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 90
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 90
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 90
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 89
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 89
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 89
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 89
Hemispheric lateralization in top-down attention during spatial relation processing: a Granger causal model approach 89
Data of safety in a single-center alemtuzumab treated population 89
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 87
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 87
Autoscopic phenomena: case report and review of literature. 87
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 87
Olanzapine enhances anxiety response to an SSRI in a woman with bipolar disorder 87
Il morbo di Parkinson 86
Fronto-Parietal network subserving behaviour: the contributions of Supplementary Motor and Dorso-lateral Prefrontal Cortex in fluid reasoning. 86
Paradoxical kinesia in parkinsonian patients surviving earthquake. 86
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 85
Use of some alkanoyl L-carnitines for the manifacture of a medicament fot therapeutical treatment of idiopathic and induced Parkinsonism. 85
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 85
Asymptomatic carotid acute dissection following focal status epilepticus. 85
Viral encephalitis in Parry-Romberg syndrome. 85
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 85
Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial 85
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 85
3D localization of interictal epileptic activity by neuromagnetic method 84
Heat shock protein 70: implication for Alzheimer's disease 84
Pathological Gambling in PD is reduced by Amantadine 84
Polymorphisms of chemokine receptor genes in Alzheimer's and Parkinson's Patients 84
Low- and high-frequency evoked responses following pattern reversal stimuli: A MEG study supported by fMRI constraint 84
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism 84
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 84
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 84
Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery 84
Registrazioni dei potenziali evocati visivi ed evento_correlati in un paziente affetto da sindrome di Balint 83
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 83
Cerebral mapping in patients with multifocal diffractive intraocular lens 83
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 83
Totale 10.869
Categoria #
all - tutte 162.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020613 0 0 0 0 0 0 0 0 0 0 570 43
2020/20213.012 475 41 513 76 226 595 76 73 199 374 194 170
2021/20222.267 65 44 52 234 133 82 79 221 219 80 315 743
2022/20237.654 636 980 490 811 716 1.449 457 537 930 105 212 331
2023/20243.724 241 153 268 166 220 1.067 801 181 65 117 67 378
2024/20256.745 508 1.566 1.324 242 256 359 389 541 807 543 210 0
Totale 36.567